Bristol-Myers Squibb
BMY
#201
Rank
โ‚ฌ88.66 B
Marketcap
43,55ย โ‚ฌ
Share price
-1.97%
Change (1 day)
-18.84%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2025 (TTM): โ‚ฌ43.03 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is โ‚ฌ41.30 Billion. In 2024 the company made a revenue of โ‚ฌ46.41 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ40.71 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ43.03 B-7.28%
2024 โ‚ฌ46.41 B14.01%
2023 โ‚ฌ40.71 B-5.39%
2022 โ‚ฌ43.03 B5.06%
2021 โ‚ฌ40.95 B18.49%
2020 โ‚ฌ34.56 B48.11%
2019 โ‚ฌ23.33 B18.34%
2018 โ‚ฌ19.72 B13.89%
2017 โ‚ฌ17.31 B-6.25%
2016 โ‚ฌ18.46 B21.95%
2015 โ‚ฌ15.14 B16%
2014 โ‚ฌ13.05 B10.04%
2013 โ‚ฌ11.86 B-10.94%
2012 โ‚ฌ13.32 B-18.57%
2011 โ‚ฌ16.35 B11.68%
2010 โ‚ฌ14.64 B25.69%
2009 โ‚ฌ11.65 B-20.9%
2008 โ‚ฌ14.73 B17.66%
2007 โ‚ฌ12.52 B-7.77%
2006 โ‚ฌ13.57 B-16.27%
2005 โ‚ฌ16.21 B25.22%
2004 โ‚ฌ12.94 B-22.45%
2003 โ‚ฌ16.69 B-3.66%
2002 โ‚ฌ17.33 B-20.19%
2001 โ‚ฌ21.71 B7.27%
2000 โ‚ฌ20.24 B5.17%
1999 โ‚ฌ19.25 B24.94%
1998 โ‚ฌ15.40 B9.48%
1997 โ‚ฌ14.07 B10.86%
1996 โ‚ฌ12.69 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ53.98 B 30.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.23 B 33.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ51.09 B 23.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.47 B 17.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ40.86 B-1.06%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
โ‚ฌ49.98 B 21.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ79.23 B 91.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.28 B 24.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.93 B-25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.65 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA